Highland Long/Short Healthcare Fund Class A (HHCAX)

13.22
Net Asset Value
+1.07%
1 Day
+9.26%
Year-to-Date
Overall Morningstar Rating
Long-short equity
Style or Category
5.5
Sales Expenses
2.80%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund seeks to achieve its investment objective by investing at least 80% of the value of its total assets (net assets plus any borrowings for investment purposes) under normal circumstances in securities of companies principally engaged in the design- development- production- sale- management or distribution of products- services or facilities used for or in connection with healthcare or medicine ("healthcare companies"). It is non-diversified.

Performance

1 month+4.84% 3 years-5.28%
3 months+10.81% 5 years+5.67%
1 year+18.99% Since inception+4.94%
Data through --

Peer Comparisonvs. Long-short equity

 HHCAXCategory
Performance 5-yr return+5.67%+4.49%
Expense ratio2.80%1.89%
Risk 5 year sharpe ratio0.340.52
Net assets$57.8M$340.5M
Average market cap$5.2B$43.5B
Average P/E--17.5
Portfolio turnover964%964%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyHighland Funds
Fund manager & tenureAndrew Hilgenbrink / 0 Years
Minimal initial investment$2,500.00
Minimum IRA investment$50.00

Holdings

U.S. stock86.18%
International stock12.68%
Fixed income1.15%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 94.68%
Hardware 2.03%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Top 10 Holdings
Portfolio weighting
SHPG Shire12.25%
-- 11.61%
NERV Minerva Neurosciences Inc9.37%
ABT Abbott Laboratories8.36%
BIO Bio Rad Laboratories Inc8.30%
QHC Quorum Health Corp6.42%
-- 5.86%
VRTX Vertex Pharmaceuticals Inc5.14%
RHHBY Roche4.33%
LHCG LHC Group Inc3.88%